FDA Drug Application (205412) for ABACAVIR SULFATE; LAMIVUDINE by HETERO LABS LTD V

Back to FDA Applications sponsored by HETERO LABS LTD V

Application Number205412
Product Number001
FormTABLET;ORAL
Dosage600;300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABACAVIR SULFATE; LAMIVUDINE
Active IngredientABACAVIR SULFATE;LAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient ABACAVIR SULFATE9
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by HETERO LABS LTD V